South America Brucellosis Market

ID: MRFR/LS/51834-HCR
200 Pages
Vikita Thakur
Last Updated: February 06, 2026
South America Brucellosis Market Research Report By species (Brucella suis, B. abortus, B. melitensis) and By Regional (Brazil, Mexico, Argentina, Rest of South America) -Forecast to 2035
South America Brucellosis Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.97%
2024 Market Size$ 32.88 Million
2025 Market Size$ 35.17 Million
2035 Market Size$ 69.01 Million
Key Players
Zoetis Inc
Merck & Co Inc
Boehringer Ingelheim GmbH
Ceva Santé Animale
Vetoquinol SA
Heska Corporation
Trends
  • Increased Regulatory Measures
  • Technological Advancements in Diagnostics
  • Collaboration Between Sectors
Opportunities
  • Rising Incidence of Brucellosis
  • Increased Awareness and Education
  • Government Initiatives and Funding
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Species (USD Million)
      1. 4.1.1 Brucella suis
      2. 4.1.2 Brucella abortus
      3. 4.1.3 Brucella melitensis
      4. 4.1.4 Brucella canis
      5. 4.1.5 others
    2. 4.2 Healthcare, BY Diagnosis (USD Million)
      1. 4.2.1 serological tests
      2. 4.2.2 molecular techniques
      3. 4.2.3 bone marrow biopsy
      4. 4.2.4 X-rays
      5. 4.2.5 computerized tomography (CT)
      6. 4.2.6 magnetic resonance imaging (MRI)
      7. 4.2.7 cerebrospinal fluid culture
      8. 4.2.8 echocardiography
      9. 4.2.9 others
    3. 4.3 Healthcare, BY Treatment (USD Million)
      1. 4.3.1 antibiotics
      2. 4.3.2 vaccines
      3. 4.3.3 others
    4. 4.4 Healthcare, BY End-User (USD Million)
      1. 4.4.1 hospitals & diagnostic centers
      2. 4.4.2 academic institutes
      3. 4.4.3 pharmaceutical & biotechnology companies
      4. 4.4.4 others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Zoetis Inc (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Merck & Co Inc (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Boehringer Ingelheim GmbH (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Ceva Santé Animale (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Vetoquinol SA (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Heska Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Elanco Animal Health Incorporated (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Virbac SA (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY SPECIES
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY DIAGNOSIS
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY TREATMENT
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END-USER
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY SPECIES, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY SPECIES, 2024 TO 2035 (USD Million)
    14. 6.14 HEALTHCARE, BY DIAGNOSIS, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
    16. 6.16 HEALTHCARE, BY TREATMENT, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY TREATMENT, 2024 TO 2035 (USD Million)
    18. 6.18 HEALTHCARE, BY END-USER, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SPECIES, 2025-2035 (USD Million)
      2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
      3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America South America Brucellosis Market Segmentation

South America Brucellosis Market By Species (USD Million, 2025-2035)

  • Brucella suis
  • Brucella abortus
  • Brucella melitensis
  • Brucella canis
  • others

South America Brucellosis Market By Diagnosis (USD Million, 2025-2035)

  • serological tests
  • molecular techniques
  • bone marrow biopsy
  • X-rays
  • computerized tomography (CT)
  • magnetic resonance imaging (MRI)
  • cerebrospinal fluid culture
  • echocardiography
  • others

South America Brucellosis Market By Treatment (USD Million, 2025-2035)

  • antibiotics
  • vaccines
  • others

South America Brucellosis Market By End-User (USD Million, 2025-2035)

  • hospitals & diagnostic centers
  • academic institutes
  • pharmaceutical & biotechnology companies
  • others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.